Caeruleus Genomics has developed a proprietary discovery platform to profile disease multimodally and with unprecedented accuracy. To do this, we overcame the core bottlenecks to industrialising single-cell long-read sequencing. 

We use our in-house computational and sequencing platform to profile human tissues functionally, uncover new RNA targets and develop more effective therapies in oncology and rare diseases. 

Spun out from Oxford University by experts in functional genomics, therapeutic target discovery and computational biology.

Biotechnology

Life Sciences

Caeruleus Genomics

Caeruleus Genomics' headquarters in Oxford, United Kingdom

Description

People (2)

Peter Crane

Adam Cribbs

Jobs